MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AMLX — Amylyx Pharmaceuticals, Inc. Common Stock
NasdaqAmylyx Pharmaceuticals, Inc. Common Stock
$27.79
-0.29(-1.03%)
- O
- 28.50
- H
- 28.81
- L
- 27.64
- V
- 912.33K
⏱️ End-of-day dataAs of Oct 2, 2026
AMLX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $22.91M | $22.67M | $22.52M | $58.09M | $59.76M | $77.39M |
| Other Short Term Investments | $50.63M | $90.33M | $11.88M | $12.27M | $14.43M | $99.11M |
| Other Current Assets | $5.26M | $6.60M | $9.26M | $5.96M | $11.78M | $12.48M |
| Total Current Assets | $28.50M | $32.37M | $35.34M | $18.69M | $21.61M | $18.94M |
| Properties | $5.09M | $5.18M | $5.88M | $6.26M | $2.07M | $1.77M |
| Other Non Current Assets | $3.49M | $3.48M | $3.48M | $1.45M | $1.46M | $1.47M |
| Total Non Current Assets | $8.58M | $8.97M | $9.36M | $7.71M | $3.53M | $4.20M |
| Total Assets | $29.36M | $33.26M | $36.27M | $19.46M | $21.97M | $19.36M |
| Accounts Payable | $3.53M | $3.52M | $5.34M | $3.29M | $4.81M | $2.94M |
| Accrued Expenses | $8.09M | $7.86M | $9.66M | $10.52M | $7.70M | $13.96M |
| Short Term Debt | $1.16M | $1.26M | 981,000.00 | 665,000.00 | $1.05M | $1.52M |
| Pensions | $3.20M | $10.05M | $9.81M | $6.95M | $4.37M | $9.99M |
| Total Current Liabilities | $15.97M | $22.69M | $25.79M | $21.42M | $17.93M | $28.41M |
| Long Term Debt | $4.48M | $4.70M | $4.95M | $5.30M | 327,000.00 | 463,000.00 |
| Total Non Current Liabilities | $4.48M | $4.70M | $4.95M | $5.30M | 327,000.00 | 463,000.00 |
| Total Liabilities | $20.44M | $27.39M | $30.75M | $26.72M | $18.26M | $28.87M |
| Common Stock | 11,000.00 | 11,000.00 | 11,000.00 | 9,000.00 | 9,000.00 | 7,000.00 |
| Retained Earnings | $-79.27M | $-75.14M | $-71.84M | $-68.40M | $-64.26M | $-60.67M |
| Other Shareholders Equity | 240,000.00 | 404,000.00 | 815,000.00 | 551,000.00 | 0.00 | -92,000.00 |
| Total Shareholders Equity | $27.32M | $30.53M | $33.20M | $16.79M | $20.14M | $16.48M |
| Additional Paid In Capital | $106.56M | $105.63M | $104.96M | $85.14M | $84.40M | $77.15M |
| Accounts Receivable | N/A | 88,000.00 | 132,000.00 | 103,000.00 | 300,000.00 | 447,000.00 |
| Machinery Furniture Equipment | N/A | $1.69M | N/A | N/A | N/A | $1.92M |
| Construction In Progress | N/A | 19,000.00 | N/A | N/A | N/A | 221,000.00 |
| Leases | N/A | 154,000.00 | N/A | N/A | N/A | 176,000.00 |
| Accumulated Depreciation | N/A | $-1.55M | N/A | N/A | N/A | $-1.36M |
| Inventory | N/A | N/A | N/A | N/A | N/A | 0.00 |